Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1377

1.

Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism.

Su TH, Yang HC, Tseng TC, Chou SW, Lin CH, Liu CH, Liu CJ, Chen CL, Kao JH.

Mov Disord. 2019 Sep 10. doi: 10.1002/mds.27848. [Epub ahead of print]

PMID:
31505068
2.

High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.

Tseng TC, Liu CJ, Hsu CY, Hong CM, Su TH, Yang WT, Chen CL, Yang HC, Huang YT, Fang-Tzu Kuo S, Liu CH, Chen PJ, Chen DS, Kao JH.

Gastroenterology. 2019 Aug 27. pii: S0016-5085(19)41248-1. doi: 10.1053/j.gastro.2019.08.028. [Epub ahead of print]

PMID:
31470004
3.

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium.

Huang CF, Iio E, Jun DW, Ogawa E, Toyoda H, Hsu YC, Haga H, Iwane S, Enomoto M, Lee DH, Wong G, Liu CH, Tada T, Chuang WL, Cheung R, Hayashi J, Tseng CH, Yasuda S, Tran S, Kam L, Henry L, Jeong JY, Nomura H, Park SH, Nakamuta M, Huang JF, Tai CM, Lo GH, Lee MH, Yang HI, Kao JH, Tamori A, Eguchi Y, Ueno Y, Furusyo N, Tanaka Y, Yu ML, Nguyen MH; REAL-C Investigators.

Hepatol Int. 2019 Sep;13(5):587-598. doi: 10.1007/s12072-019-09974-z. Epub 2019 Aug 28.

PMID:
31463665
4.

Trouble at the junction: When myopathy and myasthenia overlap.

Nicolau S, Kao JC, Liewluck T.

Muscle Nerve. 2019 Aug 26. doi: 10.1002/mus.26676. [Epub ahead of print] Review.

PMID:
31449669
5.

Three-dimensional modeling of human neurodegeneration: brain organoids coming of age.

Grenier K, Kao J, Diamandis P.

Mol Psychiatry. 2019 Aug 23. doi: 10.1038/s41380-019-0500-7. [Epub ahead of print] Review.

PMID:
31444473
6.

Defining protein pattern differences among molecular subtypes of diffuse gliomas using mass spectrometry.

Djuric U, Lam KHB, Kao J, Batruch I, Jevtic S, Papaioannou MD, Diamandis PE.

Mol Cell Proteomics. 2019 Jul 28. pii: mcp.RA119.001521. doi: 10.1074/mcp.RA119.001521. [Epub ahead of print]

7.

Successful treatment of nasal-type extra-nodal natural killer/T cell lymphoma with simultaneous involvement of the thyroid, liver, and pancreas.

Chang SH, Kao JH, Liang JD, Wu SJ.

Ann Hematol. 2019 Sep;98(9):2243-2246. doi: 10.1007/s00277-019-03752-5. Epub 2019 Jul 6. No abstract available.

PMID:
31280335
8.

Citronellol Induces Necroptosis of Human Lung Cancer Cells via TNF-α Pathway and Reactive Oxygen Species Accumulation.

Yu WN, Lai YJ, Ma JW, Ho CT, Hung SW, Chen YH, Chen CT, Kao JY, Way TD.

In Vivo. 2019 Jul-Aug;33(4):1193-1201. doi: 10.21873/invivo.11590.

9.

Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C.

Hsu SJ, Chiu MC, Fang YJ, Yang TH, Yu JJ, Chen CC, Kuo CC, Lee JY, Chen CH, Chen DS, Kao JH.

J Formos Med Assoc. 2019 Aug;118(8):1187-1192. doi: 10.1016/j.jfma.2019.06.014. Epub 2019 Jul 3.

10.

Antiproliferation for Breast Cancer Cells by Ethyl Acetate Extract of Nepenthes thorellii x (ventricosa x maxima).

Ou-Yang F, Tsai IH, Tang JY, Yen CY, Cheng YB, Farooqi AA, Chen SR, Yu SY, Kao JK, Chang HW.

Int J Mol Sci. 2019 Jul 1;20(13). pii: E3238. doi: 10.3390/ijms20133238.

11.

Letter: contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan. Authors' reply.

Liu CH, Kao JH.

Aliment Pharmacol Ther. 2019 Jul;50(1):115-116. doi: 10.1111/apt.15329. No abstract available.

PMID:
31184389
12.

Can propranolol prevent progression of melanoma?

Kao J, Luu B.

JAAPA. 2019 Jun;32(6):1-5. doi: 10.1097/01.JAA.0000558241.84003.91.

PMID:
31136408
13.

Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota.

Hsu PI, Pan CY, Kao JY, Tsay FW, Peng NJ, Kao SS, Chen YH, Tsai TJ, Wu DC, Tsai KW.

J Gastroenterol Hepatol. 2019 May 22. doi: 10.1111/jgh.14736. [Epub ahead of print]

PMID:
31115933
14.

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease.

Shen TJ, Jhan MK, Kao JC, Ho MR, Tsai TT, Tseng PC, Wang YT, Lin CF.

J Vis Exp. 2019 Apr 28;(146). doi: 10.3791/59132.

PMID:
31081826
15.

Proteomic analysis of meningiomas reveals clinically-distinct molecular patterns.

Papaioannou MD, Djuric U, Kao J, Karimi S, Zadeh G, Aldape K, Diamandis P.

Neuro Oncol. 2019 May 11. pii: noz084. doi: 10.1093/neuonc/noz084. [Epub ahead of print]

PMID:
31077268
16.

Improved quantitative assessment of HBV-associated liver fibrosis using second-harmonic generation microscopy with feature selection.

Hsiao CY, Teng X, Su TH, Lee PH, Kao JH, Huang KW.

Clin Res Hepatol Gastroenterol. 2019 May 7. pii: S2210-7401(19)30093-2. doi: 10.1016/j.clinre.2019.04.003. [Epub ahead of print]

17.

Early Childhood Anemia in a Birth Cohort in Coastal Kenya: Links to Infection and Nutrition.

Kao J, Mutuku F, Martin S, Lee J, Mwandi J, Mukoko D, Malhotra I, King CH, LaBeaud AD.

Am J Trop Med Hyg. 2019 Jul;101(1):242-252. doi: 10.4269/ajtmh.17-0688.

18.

NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging.

Su TH, Liao SH, Hong CM, Liu CJ, Tseng TC, Liu CH, Yang HC, Chen PJ, Chen DS, Chen CL, Adhoute X, Bourlière M, Kao JH.

J Gastroenterol Hepatol. 2019 May 7. doi: 10.1111/jgh.14705. [Epub ahead of print]

PMID:
31062879
19.

Citrobacter rodentium Induces Tissue-Resident Memory CD4+ T Cells.

Bishu S, Hou G, El Zaatari M, Bishu SR, Popke D, Zhang M, Grasberger H, Zou W, Stidham RW, Higgins PDR, Spence JR, Kamada N, Kao JY.

Infect Immun. 2019 Jun 20;87(7). pii: e00295-19. doi: 10.1128/IAI.00295-19. Print 2019 Jul.

PMID:
31061145
20.

Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotyping.

Kao JH, Lin CY, Chuang WL, Cheng YY, Hu JY, Liang WK, Friebe P, Palmer S, Huang CS.

Diagn Microbiol Infect Dis. 2019 Aug;94(4):344-348. doi: 10.1016/j.diagmicrobio.2019.02.020. Epub 2019 Mar 12.

PMID:
30975461
21.

Curcumin Promotes Connexin 43 Degradation and Temozolomide-Induced Apoptosis in Glioblastoma Cells.

Huang BR, Tsai CH, Chen CC, Way TD, Kao JY, Liu YS, Lin HY, Lai SW, Lu DY.

Am J Chin Med. 2019;47(3):657-674. doi: 10.1142/S0192415X19500344. Epub 2019 Apr 11.

PMID:
30974966
22.

Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.

Wei L, Pavlovic V, Bansal AT, Chen X, Foster GR, He H, Kao JH, Lampertico P, Liaw YF, Motoc A, Papatheodoridis GV, Piratvisuth T, Plesniak R, Wat C.

J Viral Hepat. 2019 Sep;26(9):1040-1049. doi: 10.1111/jvh.13107. Epub 2019 Jul 23.

PMID:
30972912
23.

An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naïve chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE): Impact of baseline viral loads and NS5A resistance-associated substitution.

Huang CF, Hung CH, Cheng PN, Bair MJ, Huang YH, Kao JH, Hsu SJ, Lee PL, Chen JJ, Chien RN, Peng CY, Lin CY, Hsieh TY, Cheng CH, Dai CY, Huang JF, Chuang WL, Yu ML.

J Infect Dis. 2019 Apr 8. pii: jiz154. doi: 10.1093/infdis/jiz154. [Epub ahead of print]

PMID:
30957170
24.

Release parameters during progressive degeneration of dopamine neurons in a mouse model reveal earlier impairment of spontaneous than forced behaviors.

Chen YH, Hsieh TH, Kuo TT, Kao JH, Ma KH, Huang EY, Chou YC, Olson L, Hoffer BJ.

J Neurochem. 2019 Jul;150(1):56-73. doi: 10.1111/jnc.14702. Epub 2019 May 9.

PMID:
30933310
25.

Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis.

Liu CH, Shih YL, Yang SS, Lin CL, Fang YJ, Cheng PN, Chen CY, Peng CY, Hsieh TY, Chiu YC, Su TH, Liu CJ, Yang HC, Chen PJ, Chen DS, Kao JH.

J Gastroenterol Hepatol. 2019 Apr 1. doi: 10.1111/jgh.14672. [Epub ahead of print]

PMID:
30931537
26.

Publisher Correction: Brain-machine interface cursor position only weakly affects monkey and human motor cortical activity in the absence of arm movements.

Stavisky SD, Kao JC, Nuyujukian P, Pandarinath C, Blabe C, Ryu SI, Hochberg LR, Henderson JM, Shenoy KV.

Sci Rep. 2019 Mar 28;9(1):5528. doi: 10.1038/s41598-018-37930-8.

27.

Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done.

Hsu YC, Tseng CH, Kao JH.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):1000-1001. doi: 10.1016/j.cgh.2018.09.002. No abstract available.

PMID:
30902225
28.

Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: a systematic review and meta-analysis of individual participant data.

Pavlovic V, Yang L, Chan HL, Hou J, Janssen HL, Kao JH, Lampertico P, Peng CY, Piratvisuth T, Thompson AJ, Wedemeyer H, Wei L, Wat C.

Antivir Ther. 2019;24(2):133-140. doi: 10.3851/IMP3304.

PMID:
30865588
29.

Performance of Acoustic Radiation Force Impulse Elastography for Staging Liver Fibrosis in Patients with Chronic Hepatitis C after Viral Eradication.

Chen SH, Lai HC, Chiang IP, Su WP, Lin CH, Kao JT, Chuang PH, Hsu WF, Wang HW, Chen HY, Huang GT, Peng CY.

Clin Infect Dis. 2019 Feb 28. pii: ciz161. doi: 10.1093/cid/ciz161. [Epub ahead of print]

PMID:
30816416
30.

Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Li YT, Wu HL, Kao JH, Cheng HR, Ho MC, Wang CC, Chen PJ, Chen DS, Liu CJ.

Hepatology. 2019 Jul;70(1):184-197. doi: 10.1002/hep.30581. Epub 2019 Apr 14.

PMID:
30802976
31.

Sarcopenia and chronic liver diseases.

Hsu CS, Kao JH.

Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1229-1244. doi: 10.1080/17474124.2018.1534586. Epub 2018 Oct 16. Review.

PMID:
30791794
32.

Reply.

Kao JY, Wu DC.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1647-1648. doi: 10.1016/j.cgh.2019.02.015. Epub 2019 Feb 13. No abstract available.

PMID:
30771498
33.

IL-10 produced by macrophages regulates epithelial integrity in the small intestine.

Morhardt TL, Hayashi A, Ochi T, Quirós M, Kitamoto S, Nagao-Kitamoto H, Kuffa P, Atarashi K, Honda K, Kao JY, Nusrat A, Kamada N.

Sci Rep. 2019 Feb 4;9(1):1223. doi: 10.1038/s41598-018-38125-x.

34.

CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor α in Active Crohn's Disease.

Bishu S, El Zaatari M, Hayashi A, Hou G, Bowers N, Kinnucan J, Manoogian B, Muza-Moons M, Zhang M, Grasberger H, Bourque C, Zou W, Higgins PDR, Spence JR, Stidham RW, Kamada N, Kao JY.

J Crohns Colitis. 2019 Jul 25;13(7):905-915. doi: 10.1093/ecco-jcc/jjz010.

PMID:
30715262
35.

The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogue Cessation Among Asian Chronic Hepatitis B Patients: Friend or Foe?

Wang CC, Kao JH.

Hepatology. 2019 Apr;69(4):1843. doi: 10.1002/hep.30532. Epub 2019 Mar 18. No abstract available.

PMID:
30703245
36.

Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection.

Liu CH, Su TH, Liu CJ, Hong CM, Yang HC, Tseng TC, Chen PJ, Chen DS, Kao JH.

J Gastroenterol Hepatol. 2019 Jan 29. doi: 10.1111/jgh.14615. [Epub ahead of print]

PMID:
30693965
37.

Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma.

Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH.

Aliment Pharmacol Ther. 2019 Mar;49(5):589-598. doi: 10.1111/apt.15132. Epub 2019 Jan 25.

PMID:
30681172
38.

Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study.

Cho Y, Sautenet B, Gutman T, Rangan G, Craig JC, Ong AC, Chapman A, Ahn C, Coolican H, Kao JT, Gansevoort R, Perrone RD, Harris T, Torres V, Pei Y, Kerr PG, Ryan J, Johnson DW, Viecelli AK, Geneste C, Kim H, Kim Y, Oh YK, Teixeira-Pinto A, Logeman C, Howell M, Ju A, Manera KE, Tong A.

Nephrology (Carlton). 2019 Jan 20. doi: 10.1111/nep.13566. [Epub ahead of print]

PMID:
30663163
39.

Early timing of single balloon enteroscopy is associated with increased diagnostic yield in patients with overt small bowel bleeding.

Tu CH, Kao JY, Tseng PH, Lee YC, Chiang TH, Chen CC, Wang HP, Chiu HM, Wu MS.

J Formos Med Assoc. 2019 Jan 17. pii: S0929-6646(18)30526-6. doi: 10.1016/j.jfma.2019.01.003. [Epub ahead of print]

40.

Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection.

Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH.

Aliment Pharmacol Ther. 2019 Feb;49(3):331-339. doi: 10.1111/apt.15101. Epub 2018 Dec 27.

PMID:
30592071
41.

Editorial: nephrotoxicity and oral anti-viral therapy for HBV-facts or fiction?

Liu CH, Kao JH.

Aliment Pharmacol Ther. 2019 Jan;49(2):229-230. doi: 10.1111/apt.15056. No abstract available.

PMID:
30589963
42.

Effects of Anti-Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases.

Lin KD, Chiu GF, Waljee AK, Owyang SY, El-Zaatari M, Bishu S, Grasberger H, Zhang M, Wu DC, Kao JY.

Clin Gastroenterol Hepatol. 2019 Sep;17(10):1991-1999. doi: 10.1016/j.cgh.2018.12.014. Epub 2018 Dec 20.

PMID:
30580094
43.

Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan.

Liu CH, Liu CJ, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Kao JH.

PLoS One. 2018 Dec 21;13(12):e0209299. doi: 10.1371/journal.pone.0209299. eCollection 2018.

44.

GSK-3 inhibitors enhance TRAIL-mediated apoptosis in human gastric adenocarcinoma cells.

Wu YY, Hsieh CT, Chiu YM, Chou SC, Kao JT, Shieh DC, Lee YJ.

PLoS One. 2018 Dec 17;13(12):e0208094. doi: 10.1371/journal.pone.0208094. eCollection 2018.

45.
46.

APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?

Kanda T, Lau GKK, Wei L, Moriyama M, Yu ML, Chuang WL, Ibrahim A, Lesmana CRA, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Mamun-Al-Mahtab, McCaughan GW, Wasim J, Crawford DHG, Kao JH, Yokosuka O, Sarin SK, Omata M.

Hepatol Int. 2019 Mar;13(2):103-109. doi: 10.1007/s12072-018-9915-5. Epub 2018 Dec 11.

47.

Real-time local oxygen measurements for high resolution cellular imaging.

Boyman L, Williams GSB, Wescott AP, Leach JB, Kao JPY, Lederer WJ.

J Mol Cell Cardiol. 2019 Feb;127:97-104. doi: 10.1016/j.yjmcc.2018.11.021. Epub 2018 Dec 5.

PMID:
30528909
48.

Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions.

Yu ML, Hung CH, Huang YH, Peng CY, Lin CY, Cheng PN, Chien RN, Hsu SJ, Liu CH, Huang CF, Su CW, Huang JF, Liu CJ, Kao JH, Chuang WL, Chen PJ, Chen DS.

J Formos Med Assoc. 2019 Feb;118(2):556-564. doi: 10.1016/j.jfma.2018.11.007. Epub 2018 Dec 5.

49.

Taiwan consensus statement on the management of chronic hepatitis B.

Chien RN, Kao JH, Peng CY, Chen CH, Liu CJ, Huang YH, Hu TH, Yang HI, Lu SN, Ni YH, Chuang WL, Lee CM, Wu JC, Chen PJ, Liaw YF.

J Formos Med Assoc. 2019 Jan;118(1 Pt 1):7-38. doi: 10.1016/j.jfma.2018.11.008. Epub 2018 Dec 6.

50.

A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment.

Liu YT, Tseng TC, Soong RS, Peng CY, Cheng YH, Huang SF, Chuang TH, Kao JH, Huang LR.

J Immunother Cancer. 2018 Dec 7;6(1):144. doi: 10.1186/s40425-018-0462-3.

Supplemental Content

Support Center